Cargando…

The mortality burden of hematological malignancies in Ecuador

BACKGROUND: The Hematological neoplasms (HN) are a heterogeneous group of cancers that originated in the hematopoietic or lymphoid tissues. There is reduced information published regarding HN mortality in Ecuador. This study aims to present the crude and age-specific mortality rates for HN in the Ec...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrido, David, Orquera, Andrés, Rojas, Johanna, Granja, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Nepal Epidemiological Association 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266404/
https://www.ncbi.nlm.nih.gov/pubmed/34290894
http://dx.doi.org/10.3126/nje.v11i2.37057
_version_ 1783719940179623936
author Garrido, David
Orquera, Andrés
Rojas, Johanna
Granja, Manuel
author_facet Garrido, David
Orquera, Andrés
Rojas, Johanna
Granja, Manuel
author_sort Garrido, David
collection PubMed
description BACKGROUND: The Hematological neoplasms (HN) are a heterogeneous group of cancers that originated in the hematopoietic or lymphoid tissues. There is reduced information published regarding HN mortality in Ecuador. This study aims to present the crude and age-specific mortality rates for HN in the Ecuadorian population. METHODS: We performed a cross-sectional study through the national database of defunctions published by the Ecuadorian National Institute of Statistics and Census, 2019. We used the ICD-10 codes to classify the HN. RESULTS: During 2019, 1462 deaths were reported, 53.83% were males, 87.96% of mestizo ethnicity, and 78.32% residents in urban areas. The median age was 62 years, with an interquartile range of 34. The crude mortality rate obtained was 8.49 per 100000 inhabitants, and the higher age-specific mortality rates was 43.29 per 100000 inhabitants aged ≥ 60 years, contrasting with the 2.63 per 100000 inhabitants in people aged < 20 years. Considering each ICD-10 group, we found the following rates by 100000 inhabitants; C85 2.04, C91 1.92, C92 1.46, C90 1.11, C83 0.70, C95 0.48, C81 0.38, C84 0.16, C82 0.10, C96 0.05, C93 0.04, C86 and C94 0.02, and C88 0.01. CONCLUSION: In Ecuador, during 2019, approximately eight people died due to HN by 100000 inhabitants, affecting mainly people aged ≥ 60 years. The most frequent neoplasms were Non-Hodgkin lymphomas, similar to other reports globally. These results should be analyzed considering some deficiencies in the Ecuadorian health system and the national registry. Therefore, we suggest conducting more studies regarding HN.
format Online
Article
Text
id pubmed-8266404
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Nepal Epidemiological Association
record_format MEDLINE/PubMed
spelling pubmed-82664042021-07-30 The mortality burden of hematological malignancies in Ecuador Garrido, David Orquera, Andrés Rojas, Johanna Granja, Manuel Nepal J Epidemiol Short Communication BACKGROUND: The Hematological neoplasms (HN) are a heterogeneous group of cancers that originated in the hematopoietic or lymphoid tissues. There is reduced information published regarding HN mortality in Ecuador. This study aims to present the crude and age-specific mortality rates for HN in the Ecuadorian population. METHODS: We performed a cross-sectional study through the national database of defunctions published by the Ecuadorian National Institute of Statistics and Census, 2019. We used the ICD-10 codes to classify the HN. RESULTS: During 2019, 1462 deaths were reported, 53.83% were males, 87.96% of mestizo ethnicity, and 78.32% residents in urban areas. The median age was 62 years, with an interquartile range of 34. The crude mortality rate obtained was 8.49 per 100000 inhabitants, and the higher age-specific mortality rates was 43.29 per 100000 inhabitants aged ≥ 60 years, contrasting with the 2.63 per 100000 inhabitants in people aged < 20 years. Considering each ICD-10 group, we found the following rates by 100000 inhabitants; C85 2.04, C91 1.92, C92 1.46, C90 1.11, C83 0.70, C95 0.48, C81 0.38, C84 0.16, C82 0.10, C96 0.05, C93 0.04, C86 and C94 0.02, and C88 0.01. CONCLUSION: In Ecuador, during 2019, approximately eight people died due to HN by 100000 inhabitants, affecting mainly people aged ≥ 60 years. The most frequent neoplasms were Non-Hodgkin lymphomas, similar to other reports globally. These results should be analyzed considering some deficiencies in the Ecuadorian health system and the national registry. Therefore, we suggest conducting more studies regarding HN. International Nepal Epidemiological Association 2021-06-30 /pmc/articles/PMC8266404/ /pubmed/34290894 http://dx.doi.org/10.3126/nje.v11i2.37057 Text en © 2021 CEA& INEA https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License.
spellingShingle Short Communication
Garrido, David
Orquera, Andrés
Rojas, Johanna
Granja, Manuel
The mortality burden of hematological malignancies in Ecuador
title The mortality burden of hematological malignancies in Ecuador
title_full The mortality burden of hematological malignancies in Ecuador
title_fullStr The mortality burden of hematological malignancies in Ecuador
title_full_unstemmed The mortality burden of hematological malignancies in Ecuador
title_short The mortality burden of hematological malignancies in Ecuador
title_sort mortality burden of hematological malignancies in ecuador
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266404/
https://www.ncbi.nlm.nih.gov/pubmed/34290894
http://dx.doi.org/10.3126/nje.v11i2.37057
work_keys_str_mv AT garridodavid themortalityburdenofhematologicalmalignanciesinecuador
AT orqueraandres themortalityburdenofhematologicalmalignanciesinecuador
AT rojasjohanna themortalityburdenofhematologicalmalignanciesinecuador
AT granjamanuel themortalityburdenofhematologicalmalignanciesinecuador
AT garridodavid mortalityburdenofhematologicalmalignanciesinecuador
AT orqueraandres mortalityburdenofhematologicalmalignanciesinecuador
AT rojasjohanna mortalityburdenofhematologicalmalignanciesinecuador
AT granjamanuel mortalityburdenofhematologicalmalignanciesinecuador